Cytotoxic activity of dendritic cells as a possible mechanism of negative regulation of T lymphocytes in pulmonary tuberculosis

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Sakhno, Ludmila V ^a   Tikhonova, Marina A ^a   Tyrinova, Tamara V ^a   Leplina, Olga Yu ^a   Shevela, Ekaterina Ya ^a   Nikonov, Sergey D ^b   Zhdanov, Oleg A ^b   Ostanin, Alexander A ^a   Chernykh, Elena R ^a  

^a INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^b Novosibirsk Tuberculosis Clinical Hospital No 1   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; PROGRAMMED DEATH 1 LIGAND 1; APOPTOSIS REGULATORY PROTEIN; BACTERIAL ANTIGEN; CD274 PROTEIN, HUMAN; GAMMA INTERFERON; IL10 PROTEIN, HUMAN; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED LYMPHOCYTE CULTURE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ADOPTIVE IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG EFFECT; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIGENS, BACTERIAL; ANTIGENS, CD274; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PROGRAMMED CELL DEATH 1 RECEPTOR; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84867843165     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/628635     Document Type: Article

References (27)

1. Leplina O. Y., Stupak V. V., Kozlov Y. P., Pendyurin I. V., Nikonov S. D., Tikhonova M. A., Sycheva N. V., Ostanin A. A., Chernykh E. R., Use of interferon- α -induced dendritic cells in the therapy of patients with malignant brain gliomas. Bulletin of Experimental Biology and Medicine 2007 143 4 528 534 2-s2.0-34648840808 10.1007/s10517-007-0172-1
2. Leplina O. Yu., Tyrinova T., Tikhonova M., Ghosh A., Direct antitumor activity of interferon-induced dendritic cells of healthy donors and patients with primary brain tumors. GliomaExploring Its Biology and Practical Relevance 2011 325 343
3. Wesa A. K., Storkus W. J., Killer dendritic cells: mechanisms of action and therapeutic implications for cancer. Cell Death and Differentiation 2008 15 1 51 57 2-s2.0-37349106381 10.1038/sj.cdd.4402243
4. Fanger N. A., Maliszewski C. R., Schooley K., Griffith T. S., Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Journal of Experimental Medicine 1999 190 8 1155 1164 2-s2.0-0032701696 10.1084/jem.190.8.1155
5. Liu S., Yu Y., Zhang M., Wang W., Cao X., The involvement of TNF- α -related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN- β -stimulated human dendritic cells to tumor cells. Journal of Immunology 2001 166 9 5407 5415 2-s2.0-0035339858
6. Curiel T. J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Krzysiek R., Knutson K. L., Daniel B., Zimmermann M. C., David O., Burow M., Gordon A., Dhurandhar N., Myers L., Berggren R., Hemminki A., Alvarez R. D., Emilie D., Curiel D. T., Chen L., Zou W., Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Medicine 2003 9 5 562 567 2-s2.0-0038273853 10.1038/nm863
7. Selenko-Gebauer N., Majdic O., Szekeres A., Höfler G., Guthann E., Korthäuer U., Zlabinger G., Steinberger P., Pickl W. F., Stockinger H., Knapp W., Stöckl J., B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. Journal of Immunology 2003 170 7 3637 3644 2-s2.0-0037377967
8. Sharpe A. H., Wherry E. J., Ahmed R., Freeman G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nature Immunology 2007 8 3 239 245 2-s2.0-34247884612 10.1038/ni1443
9. Wilcox R. A., Feldman A. L., Wada D. A., Yang Z. Z., Comfere N. I., Dong H., Kwon E. D., Novak A. J., Markovic S. N., Pittelkow M. R., Witzig T. E., Ansell S. M., B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 2009 114 10 2149 2158 2-s2.0-70349234325 10.1182/blood-2009-04-216671
10. Ye P., Weng Z. H., Zhang S. L., Zhang J. A., Zhao L., Dong J. H., Jie S. H., Pang R., Wei R. H., Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World Journal of Gastroenterology 2008 14 28 4551 4557 2-s2.0-58049104534 10.3748/wjg.14.4551
11. Das S., Suarez G., Beswick E. J., Sierra J. C., Graham D. Y., Reyes V. E., Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. Journal of Immunology 2006 176 5 3000 3009 2-s2.0-33644558718
12. Stanciu L. A., Bellettato C. M., Laza-Stanca V., Coyle A. J., Papi A., Johnston S. L., Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. Journal of Infectious Diseases 2006 193 3 404 412 2-s2.0-31044454273 10.1086/499275
13. Schreiner B., Mitsdoerffer M., Kieseier B. C., Chen L., Hartung H. P., Weller M., Wiendl H., Interferon- β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology 2004 155 1-2 172 182 2-s2.0-4444355857 10.1016/j.jneuroim.2004. 06.013
14. Trabattoni D., Saresella M., Biasin M., Boasso A., Piacentini L., Ferrante P., Dong H., Maserati R., Shearer G. M., Chen L., Clerici M., B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003 101 7 2514 2520 2-s2.0-0038784354 10.1182/blood-2002-10- 3065
15. Smith P., Walsh C. M., Mangan N. E., Fallon R. E., Sayers J. R., McKenzie A. N. J., Fallon P. G., Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. Journal of Immunology 2004 173 2 1240 1248 2-s2.0-3142750528
16. Chen L., Zhang Z., Chen W., Zhang Z., Li Y., Shi M., Zhang J., Chen L., Wang S., Wang F. S., B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. Journal of Immunology 2007 178 10 6634 6641 2-s2.0-34248185086
17. Xu H., Wang X., Pahar B., Moroney-Rasmussen T., Alvarez X., Lackner A. A., Veazey R. S., Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression. Journal of Immunology 2010 185 12 7340 7348 2-s2.0-78650644622 10.4049/jimmunol.1001642
18. Sakhno L. V., Tikhonova M. A., Ostanin A. A., Nikonov S. D., Zhdanov O. A., Chernykh E. R., Interleukin-2 in the correction of T-cell anergy in patients with pulmonary tuberculosis Problemy Tuberkuleza i Bolezne Legkikh 2006 1 48 52 2-s2.0-33645764437
19. Chernykh E. R., Sakhno L. V., Khonina M. A., Tikhonova M. A., Kozhevnikov V. S., Nikonov S. D., Zhdanov O. A., Ostanin A. A., Subpopulation belonging of T-cells subject to anergy and apoptosis in the pulmonary tuberculosis Problemy Tuberkuleza 2002 7 43 48 2-s2.0-0036988767
20. Hirsch C. S., Johnson J. L., Okwera A., Kanost R. A., Wu M., Peters P., Muhumuza M., Mayanja-Kizza H., Mugerwa R. D., Mugyenyi P., Ellner J. J., Toossi Z., Mechanisms of apoptosis of T-cells in human tuberculosis. Journal of Clinical Immunology 2005 25 4 353 364 2-s2.0-23944467147 10.1007/s10875-005- 4841-4
21. Sakhno L. V., Raspay M. Z., Tikhonova M. A., Defect of antigenpresenting cells in the patient with pulmonary tuberculosis Medical Immunology 2009 11 2-3 245 254
22. Leplina O. Y., Tikhonova M. A., Tyrinova T. V., Comparative characteristic of phenotype and cytokine-secretory activity of human dendritic cells generated in vitro with IFN-alpha and IL-4 Immunology 2012 2 60 65
23. Hanekom W. A., Mendillo M., Manca C., Haslett P. A. J., Siddiqui M. R., Barry C., Kaplan G., Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. Journal of Infectious Diseases 2003 188 2 257 266 2-s2.0-0041314099 10.1086/376451
24. Stenger S., Niazi K. R., Modlin R. L., Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. Journal of Immunology 1998 161 7 3582 3588 2-s2.0-0032194116
25. Chauvin C., Josien R., Dendritic cells as killers: mechanistic aspects and potential roles. Journal of Immunology 2008 181 1 11 16 2-s2.0-47949092667
26. D'Amico G., Frascaroli G., Bianchi G., Transidico P., Doni A., Vecchi A., Sozzani S., Allavena P., Mantovani A., Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Immunology Nature Communications 2000 1 5 387 391 2-s2.0-0034328892
27. Chang W. L. W., Baumgarth N., Eberhardt M. K., Lee C. Y. D., Baron C. A., Gregg J. P., Barry P. A., Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity. Journal of Immunology 2007 178 12 7794 7804 2-s2.0-34250175407